All In Biotech

Free tool

Drug Search

Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.

Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations

4 matches for "Rigel Pharms"

Brand names that start with your search come first, then marketed and novel drugs.

DrugSponsorApplicationFirst approvedPrograms
Gavreto

Pralsetinib

Rigel PharmsNDA213721Sep 4, 2020NovelBreakthrough therapyAccelerated approvalPriority reviewOrphan
Veppanu

Vepdegestrant

Rigel PharmsNDA219835May 1, 2026Novel
Tavalisse

Fostamatinib Disodium

Rigel PharmsNDA209299Apr 17, 2018NovelOrphan
Rezlidhia

Olutasidenib

Rigel PharmsNDA215814Dec 1, 2022NovelOrphan

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.